Compare

Insperity/$NSP

1D1W1M3M6MYTD1Y5YMAX

About Insperity

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.
Ticker
$NSP
Sector
Business services
Primary listing
NYSE
Employees
304,407

Insperity Metrics

BasicAdvanced
$1.9B
-
-$0.43
0.57
$2.40
4.78%

What the Analysts think about Insperity

Analyst ratings (Buy, Hold, Sell) for Insperity stock.
Analyst projections of the future price of Insperity stock.

Bulls say / Bears say

Q2 showed early earnings recovery: adjusted EBITDA rose 13% to $36 million and adjusted EPS rose 31% to $0.34. Full-year guidance implies adjusted EBITDA growth of 41%–72%, if the recovery plan delivers. (Yahoo Finance)
Cost control is helping offset pressure elsewhere: Q2 operating expenses fell 8% year on year, and Insperity returned to operating income of $6 million from a loss a year earlier. (StockTitan)
HRScale could open a route into the mid-market: Insperity entered Q3 with nearly 8,000 worksite employees sold, including more than 5,000 already live. Converting those early wins into sustained client growth would support the recovery beyond cost cuts. (Investing.com)
The customer base is not yet growing: Q2 paid worksite employees fell about 1%, and management forecast a 1%–2.3% decline for 2026 amid weaker small-business sentiment and pressure from its pricing and retention strategy. (The Motley Fool)
Healthcare costs remain a margin risk: Q2 benefits costs per covered employee rose about 5% while gross profit fell 3%. Management kept a wider-than-usual range for the rest of the year because medical cost trends remain elevated. (MarketScreener)
HRScale is still early and carries execution costs: about 3,000 of the worksite employees sold were still in implementation at the start of Q3, while Workday partnership expenses reached $16 million in the first half. The product must scale and convert those implementations into profitable clients to justify the investment. (Investing.com, Last10K)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2026.

Insperity Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Insperity Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Insperity

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.